Spring has sprung, and so has allergy advertising. Drugmakers blast the airwaves annually as the pollen starts to fly, with the latest sniff and cough relief remedies. But this year there's a new big ...
A battle for kids' pollen proclivities is shaping up this allergy season. Both Sanofi's ($SNY) Nasacort and GlaxoSmithKline's ($GSK) Flonase have introduced children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback